Journals / Molecular Oncologic Imaging / 2026 / Volume: 2 Issue: 2

Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma

Gökçe Yavan(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, NÜKLEER TIP ANABİLİM DALI)0000-0002-7332-6293
Zehra Pınar Koç(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, NÜKLEER TIP ANABİLİM DALI)0000-0002-3274-5790
Pınar Pelin Özcan(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, NÜKLEER TIP ANABİLİM DALI)0000-0003-0147-2678
Pages
—
Publication Date
2022-08-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we presented the a case with disseminated abdominal mass diagnosed as Burkitt Lymphoma diagnosed by FDG-PET-CT

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (18F-FDG) is currently a standard imaging examination used in clinical practice, and plays an essential role in preoperative systemic evaluation and tumor staging in various cancer patients.
📊
Key Findings & Data:With this method, it is possible to measure or compare metabolic changes in cancer cells.
💡
Conclusion & Impact:In this review, we presented the a case with disseminated abdominal mass diagnosed as Burkitt Lymphoma diagnosed by FDG-PET-CT
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:F18- FDG · PET-CT · Abdomen

Abstract

Positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (18F-FDG) is currently a standard imaging examination used in clinical practice, and plays an essential role in preoperative systemic evaluation and tumor staging in various cancer patients. With this method, it is possible to measure or compare metabolic changes in cancer cells. With combined PET/CT, it is possible to determine the correct anatomical location in hypermetabolic tumors with uptake of FDG. In this review, we presented the a case with disseminated abdominal mass diagnosed as Burkitt Lymphoma diagnosed by FDG-PET-CT

🔖

Cite This Article

Yavan, G., Koç, Z. P., Özcan, P. P. (2022). Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma. Molecular Oncologic Imaging, Volume: 2 Issue: 2. https://ajindex.com/articles/1626558

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Sachpekidis, C., Exadaktylou, P., Katsampoukas, D., Moralidis, E., & Arsos, G. (2020). 18F-FDG PET/CT in treatment response evaluation of Burkitt lymphoma: complete remission of a peritoneal super scan. Hellenic journal of nuclear medicine, 23(1), 76–78. https://doi.org/10.1967/s002449912006
  2. Zeng, W., Lechowicz, M. J., Winton, E., Cho, S. M., Galt, J. R., & Halkar, R. (2009). Spectrum of FDG PET/CT findings in Burkitt lymphoma. Clinical nuclear medicine, 34(6), 355–358. https://doi.org/10.1097/RLU.0b013e3181a34552
  3. Wang, X., Chen, Z., Tang, G., & Zhang, X. (2011). A child with Burkitt lymphoma with pleural, peritoneal, mesenteric, omental, and renal involvement: diagnostics by FDG PET/CT. Clinical nuclear medicine, 36(7), 612–615. https://doi.org/10.1097/RLU.0b013e318217af84